ABSTRACT. 1. Flavonoidsproducedaconcentration.dependentrelaxationofthecontractileresponses induced by noradrenaline, KCI, or phorbo112-myristate-13-acetate in rat aortic rings. Only the flavonoid with three contiguous hydroxyls in B rings (myricetin), at low concentrations, potentiates the contractions evoked by these agonists.
INTRODUCTION
Flavonoids are natural substances which display a broad range of pharmacological actions (Middleton, 1984; Gabor, 1986; Pathak et al., 1991) with most exhibiting vasodilatory effects (Beretz et al., 1980; Ubeda et a/., 1991; Ko et al., 1991; Duarte et al., 1993a; Duarte et al., 1993b Duarte et al., , 1994 . This vascular smooth muscle relaxation has been attributed to several mechanisms including decreased transmembrane 4SCa2÷ uptake (Ko et al., 1991; Duarte et al., 1993a) and inhibitory effects on cAMPand cGMP-phosphodiesterases (PDE; Beretz et al., 1980) or on protein kinase C (PKC) (Duarte et al., 1993a (Duarte et al., , 1993b . In a previous comparative study of seven chemically related flavonoids (favonols, flavones, and flavanols) we found that the order of potency to relax the contractions induced by different agents w as: flavonols > flavones > flavanols (Duarte et al., 1993b) . In view of these reports and to further elucidate the structure-activity relationships we have studied another seven flavonoids selected from four groups: flavonol; flavanone; flavone; and isoflavone ( Fig. 1) . We have also investigated the possible relationships between their vasodilatory responses in different experimental conditions and the reported ability to inhibit PDE and PKC.
effects of acetylcholine (10-7 to 10-5 M) in aortic rings previously contracted by 10 -7 M phenylephrine. Each preparation was allowed to equilibrate for at least 90 rain prior to initiation of experimental procedures, and during this period the incubation media were changed every 20 min.
After equilibrations, the following experiments were performed: (1) Aortic rings were contracted by single submaximal concentrations of 10 -5 M noradrenaline, 80 mM KC1 or 10 -7 M phorbol 12-myristate-13-acetate (PMA). When the contractile response to either agonist was stable, flavonoid was added in progressively increasing cumulative concentrations ( 10 -6 to 10-3 M) at 30-min intervals. Only one flavonoid was tested for each aorta. The results were expressed as a percentage of the maximal control agonist-induced responses. (2) In some aortae previously contracted by 10 -5 M noradrenaline, this protocol was repeated in the presence ofisoprenaline (10-7 M) or sodium nitroprusside (10 -8 M) added 20 min before the cumulative addition of tested flavonoid. The net relaxation of flavonoid was expressed as percent decrease in the tension existing at the moment before their administration (100%=return to baseline) (Schoeffter et al., 1987) .
MATERIALS AND METHODS

Experimental Procedure
Wistar rats (either gender, 250-300 g) were killed by a blow on the head. The descending thoracic aorta was rapidly dissected and placed in a modified Krebs-Henseleit solution (PSS) of the following composition (raM): NaCI 118, KCI 4.75, NaHCO325, MgSO41.2, CaCI21.8, KH2PO4 1.2, and glucose 11. After excess fat and connective tissue were removed, the aortae were cut into rings. Aortic rings were mounted under the basal tension of 1 g in 20-ml organ baths containing PSS and attached to a force-displacement transducer (Letigraph 2000, Letica) to measure isometric contraction force as previously described (Duarte et al., 1992) .
The tissue bath was maintained at 370C and bubbled with a 95% Oz-5% CO2 gas mixture. In some experiments, the endothelium of the aorta was mechanically removed by gently rubbing the intimal surface. The absence of endothelium was confirmed by the absence of relaxing *To whom correspondence should be addressed.
Drugs
The following drugs were used: sodium nitroprusside, (+)-noradrenaline hydrochloride, (_)-isoprenaline hydrochloride, phorbol 12-myristate-13-acetate, and naringenin (Sigma Co., London) as well as morin, myricetin, chrysin, flavanone, hesperetin, and genistein (Extrasynth~se, Genay, France). All flavonoids and PMA were initially dissolved in dimethyl sulfoxide (DMSO) to prepare a 10 -z M stock solution. Further dilutions were made in PSS with the exception of genistein which was diluted in absolute ethanol. The final ethanol or DMSO concentrations did not significantly affect the results. Ascorbic acid (10 -4 M) was added to each solution of noradrenaline and isoprenaline, made up freshly every day. significant when P<0.05. Dose-response slopes were analyzed to give the concentration of compound producing a 50% inhibition of the maximal contractile response (ICs0) using a linear regression analysis.
Statistics
RESULTS
Effects on KCI., Noradrenaline., and PMA.lnduced Contractions
Addition of high KCI (80 mM), nor adrenaline (10-s M), or PMA (10-7 M) produced a contractile response which averaged 708.0_+53.6 mg (n=41), 921.9_+ 74.4 mg (n= 39), and 497.1_+51.5 mg (n =42), respectively. At concentrations >10 -6 M, all flavonoids tested produced a concentration-dependent inhibition of the contractile responses induced by KCI ( Fig. 2) , noradrenaline ( Fig. 3) or PMA (Fig. 4) . The ICs0 values for inhibition of the contractions induced by these three agonists are compared in Table 1 . It can be observed that flavone (chrysin) and isoflavone (genistein) were the most potent drugs against the contractile response induced by the three vasoconstrictors, whereas flavonols (morin and myricetin) were the least effective agents. Myricetin induces a biphasic effect on the contractile responses induced by all of the agents M. D. Herrera et al. tested, with a potentiation at lower concentrations (<10 -5 M) and a relaxant effect at higher concentrations (>10 -s M). Flavanones (tiaranone, naringenin, and hesperetin) have an intermediate potency.
Chrysin was at least four times more potent in inhibiting noradrenalineinduced than PMA-induced contractions. In contrast, morin and naringenin were less potent inhibitors of noradrenaline contractions than those induced by the phorbol ester.
The relaxant effects of all flavonoids on noradrenaline-induced contractions were not altered by the absence of functional endothelium (not shown).
Effect of Pretreatment With Isoprenaline or Sodium Nitroprusside
Nucleotide phosphodiesterase inhibitors potentiate the relaxant effects to isoprenaline and sodium nitroprusside (Lorenz and Wells, 1983; Duarte eta/., 1992) ; both agents exert their effects in vascular smooth muscle by stimulating adenylyl cyclase or guanylyl cyclase (Hardman, 1984) and increasing intracellular cAMP or cGMP levels, respectively. In the present experiments, isoprenaline (10 -7 M) by itself produced a weak relaxation of NA-induced contractions ( -4.5 _+ 0.5 %, n--40) and potentiated the relaxant effects induced by flavanones on these contractile responses (Table 1) . Sodium nitroprusside (10 -s M) by itself rdaxed 25.3 _+ 2. I% of the maximal contractile response induced by NA. Pretreatment with this nitrovasodilator agent potentiated (P(0.05) the relaxant effects of morin, chrysin, naringenin, and flavanone on noradrenaline-induced contractions (Table 1) .
DISCUSSION
The present article describes the vasodilatory effects of seven flavonoids in rat aortic rings on the contractions induced by noradrenaline, KC1, and the phorbol ester derivative PMA, as well as the interactions of these flavonoids with both isoprenaline and sodium nitroprusside. From the present results the following structure-activity relationships can be made: (a) the flavonols tested in this study, morin and myricetin, showed from 10 to 30 times less vasodilatory potency than that previously observed with the other structurally related flavonols, quercetin and kaempferol (Duarte et al., 1993b) . Therefore, the orientation of hydroxyl groups on the B ring is important. Morin, with a 2',4' substitution pattern, is less potent than quercetin, with a Y,4' orientation. Thus, the ortho orientation on the B ring is important for the vasodilatory effect. (b) The presence of three contiguous hydroxyls in the B ring (myricetin) potentiates, at low concentrations, the contractions induced by the agonists tested. In fact, potentiation of the contractile response exerted by flavonoids possessing three contiguous hydroxyls on either the A (5,6,7-trihydroxy; baicalein, scutellarein, and quercetagetin) or B (3',4',5'-trihydroxy; myricetin) rings has been observed previously in rat tail and femoral artery to both transmural nerve stimulation-evoked and exogenous agonist-evoked contractile response (Berger et al., 1992) . The increase on the maximum contractile response was more evident when PMA was used to induce the contractions. This observation suggests that potentiation induced by myricetin may be related to the activation of protein kinase C. However, myricetin inhibits the ATP-dependent Ca 2+ transport system of rat liver plasma membrane (Thiyagarajah et al., 1991) . This inhibition is thought to serve as a mechanism for augmenting or sustaining the elevation of intracellular Ca 2+ that occurs following the release of Ca 2+ from an intracellular store (Pumey, 1990; Chen and Van Breemen, 1993) . If this also applies for vascular smooth muscle, then the myricetin-induced potentiation of contractile response to agonists could be attributed to inhibition of Ca2+-ATPase activity. However, these possible mechanisms were not investigated further in the present study. (c) The lower relaxant activity exhibited by flavanones against the contractions induced by any of the agonists tested, as compared with other flavonoids (quercetin, kaempferol, apigenin, luteolin [Duarte et al., 1993b] ; or chrysin and genistein [present results]), suggests that the presence of a double linkage C2-C3 that gives a coplanar conformation of the benzopyran ring system (i.e., flavonol, flavone, and isofiavonoid) is required for the vasodilatory activity. Moreover, flavanones are more potent agents for induction of relaxation in tissues contracted by these agonists than are flavanols [(+)-catechin and (-)-epicatechin, IC50>500 o.M] (Duarte et al., 1993b) which confirms that the presence of a 4-carbonyl group is an essential structural feature for the vasodilatory effect offlavonoids. (d) The isoflavonoid tested, genistein, also inhibited the contractions induced by noradrenaline, KCI, or PMA with similar IC50 values than that of flavonols and flavones. These results imply that position 2 or 3 of the phenyl ring is not essential for the vasodilatory activity. Tyrosine kinase inhibitors, such as genistein (Akiyama et al., 1987) selectively inhibit pervanadate-induced contractions, in both gastric and aortic preparations, without causing comparable inhibition of KCl-induced contraction (Laniyonu et al., 1994) . Because pervanadate mimics the action of the tyrosine kinase receptor-associated agonist epidermal growth factor, the inhibition of contractions evoked by the agonist tested in this study, is independent of the tyrosine kinase pathway. Moreover, the relaxant action of genistein on KCI-, noradrenaline-, or PMA-induced contractions was not likely to be due to an inhibitory action of tyrosine kinase because noradrenaline, which activates a-adrenergic receptors, or KC1 and PMA, which induce receptor-independent contractions, do not activate the tyrosine kinase pathway. However, according to our results, inhibition of phosphodiesterases or PKC cannot be ruled out as modes of action underlying the vasodilation induced by genistein. Protein kinase C (PKC) has been proposed to play a key role in maintenance of tonic contractions of vascular smooth muscle (Rasmussen et al., 1987) . Phorbol esters (i.e., PMA) activate PKC and induce a slowly developing sustained contraction in rat aorta without changing [Ca] i, possibly by increasing the Ca 2+ sensitivity of contractile proteins (Jiang and Morgan, 1987; Karaki, 1989; Duarte et al., 1994) . PKC from rat brain was inhibited by plant flavonoids in a concentrationdependent manner depending on the flavonoid structure (Ferriola et al., 1989) . In the present study, all flavonoids tested inhibit the tonic contractions induced by the PKC activator, PMA, to a similar extent to the contractions evoked by noradrenaline or KC1. Therefore, these results are in agreement with previous observations (Duarte et al., 1993b) Data are mean -+ SEM (n = 6-I1). NS = not significant. *p < 0.05 and t" p < 0.001 compared to NA.
attributing the vasodilatory effects of flavonoids to their inhibitory action on PKC. However, other mechanisms may contribute: (a) high KCl-induced contractions are due to an increased Ca 2+ influx through voltage-stimulated Ca z+ channels (Bolton 1979) . Thus, the inhibitory effects of flavonoids on these contractions may be attributed, at least partly, to the blockade of Ca 2+ entry through voltage-stimulated Ca z+ channels. (b)The potentiation induced by isoprenaline or sodium nitroprusside on the relaxant effects of flavonoids has been used as a functional test to investigate the inhibitory effects of these drugs on cAMP or cGMP phosphodiesterases, respectively (Ahn et al., 1988; Duarte et al., 1992 Duarte et al., ,1993b . in this study, only the vasodilatory effects offlavonoids without Y-hydroxyl (morin, chrysin, naringenin, and flavanone) were potentiated by sodium nitroprusside. Likewise, the effects of other flavonoids (pentamethylquercetin, apigenin, and kaempferol), which lack an hydroxyl group in position Y, are potentiated by sodium nitroprusside (Duarte et al., 1993b) . However, the potentiation by sodium nitroprusside did not parallel potentiation by isoprenaline, suggesting that these drugs are probably inhibiting cGMP-specific phosphodiesterases. However, there was no correlation between the potentiating effect of sodium nitroprusside and the ICs0 for inhibition of noradrenaline-induced contractions, suggesting that PDE inhibition is not the main mechanism of the vasodilatory action of these drugs. Furthermore, the effects of isoprenaline on the vasodilatory actions of flavonoids were heterogeneous; that is, isoprenaline either produced no change, or increases or decreases in the vasodilatory potency offlavonoids which did not appear to follow any structure-activity relationship.
In conclusion, flavonoids exert vasodilatory effects that are related to the structure of the compound tested. The main vasodilatory mechanism of flavonoids seems to be the inhibition of PKC, although an inhibitory effect on cyclic nucleotide PDE and Ca z+ uptake may also contribute to these actions.
SUMMARY
The present article describes the vasodilatory effects of seven flavonoids in rat aortic rings on contractions induced by noradrenaline, KC1, and the phorbol ester derivative PMA, as well as the interactions of these flavonoids with isoprenaline and sodium nitroprusside. The presence of double linkage C2-C3 of the benzopyran ring system increased the vasodilatory potency. The orientation of hydroxyl groups on the B ring is important for the activity: the ortho'orientation on the B ring is essential for the effect and the presence of three contiguous hydroxyls in the B ring (myricetin) potentiates the contractions induced by the agonists tested. The isoflavonoid genistein alsoinhibits the contractions evoked by the agonists tested in this study, independent of the tyrosine kinase pathway. The vasodilatory effect of flavonoids without the 3' hydroxyl group were potentiated by sodium nitroprusside, suggesting an inhibited cGMP PDE activity. The main vasodilatory mechanism of flavonoids seems to be the inhibition of PKC. An inhibitory effect of Ca 2+ uptake and cyclic nucleotide PDE may also contribute to the vasodilatory action of these drugs. This work was supported by CYCFF Grant SAF 94-0528.
